| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 01/21/1999 | CA2294533A1 6-azauracil derivatives as il-5 inhibitors |
| 01/21/1999 | CA2292451A1 Pharmaceutical compositions comprising an aldose reductase inhibitor and an ace inhibitor |
| 01/20/1999 | EP0892063A2 Histidine kinase |
| 01/20/1999 | EP0892062A2 The Chlamydia trachomatis Glutamyl-tRNAGln amidotransferase subunit ratC |
| 01/20/1999 | EP0892057A2 Response regulator |
| 01/20/1999 | EP0892049A2 A human pelota homolog |
| 01/20/1999 | EP0891984A2 Nucleic acid encoding streptococcus pneumoniae response regulator |
| 01/20/1999 | EP0891978A2 5H-Thiazolo (3,2-a) pyrimidine derivatives |
| 01/20/1999 | EP0891375A1 Peptidyl compounds having mmp and tnf- liberation inhibitory activity |
| 01/20/1999 | EP0891363A1 Heterocyclic compounds and their preparation and use |
| 01/20/1999 | EP0891361A1 Inhibitors of farnesyl-protein transferase |
| 01/20/1999 | EP0891360A1 Inhibitors of farnesyl-protein transferase |
| 01/20/1999 | EP0891357A1 Inhibitors of farnesyl-protein transferase |
| 01/20/1999 | EP0891356A1 Inhibitors of farnesyl-protein transferase |
| 01/20/1999 | EP0891355A1 Inhibitors of farnesyl-protein transferase |
| 01/20/1999 | EP0891353A1 Inhibitors of farnesyl-protein transferase |
| 01/20/1999 | EP0891352A1 Inhibitors of farnesyl-protein transferase |
| 01/20/1999 | EP0891351A1 Inhibitors of farnesyl-protein transferase |
| 01/20/1999 | EP0891350A1 Inhibitors of farnesyl-protein transferase |
| 01/20/1999 | EP0891349A1 Inhibitors of farnesyl-protein transferase |
| 01/20/1999 | EP0891343A1 Inhibitors of farnesyl-protein transferase |
| 01/20/1999 | EP0891337A1 Inhibitors of farnesyl-protein transferase |
| 01/20/1999 | EP0891335A1 Inhibitors of farnesyl-protein transferase |
| 01/20/1999 | EP0891334A1 Inhibitors of farnesyl-protein transferase |
| 01/20/1999 | EP0891332A1 6-phenylpyridyl-2-amine derivatives |
| 01/20/1999 | EP0891329A1 Peptidyl compounds having mmp and tnf inhibitory activity |
| 01/20/1999 | EP0891328A1 Peptidyl compounds having mmp and tnf inhibitory activity |
| 01/20/1999 | EP0891325A1 Para-substituted phenylpropanoic acid derivatives as integrin antagonists |
| 01/20/1999 | EP0655911B1 Ophthalmological preparation |
| 01/20/1999 | CN1205704A 2,7-substituted octahydro-pyrrolo (1,2-A) pyrazine derivatives |
| 01/19/1999 | US5861497 Trabecular meshwork induced glucocorticoid response (TIGR) nucleic acid molecules |
| 01/19/1999 | US5861436 Inhibitors of the relese of tumor necrosis factor |
| 01/19/1999 | US5861401 Treatment of congestive heart failure |
| 01/19/1999 | US5861309 Amino acid sequences encoding it, vectors for its expression in yeast, bacterial, and mammalian cells; research into the characterization of the pharmacology of individual human alpha 1 receptor subtypes |
| 01/19/1999 | US5861281 Lacc |
| 01/18/1999 | CA2237050A1 Histidine kinase |
| 01/18/1999 | CA2237043A1 Response regulator |
| 01/15/1999 | CA2220849A1 A human pelota homolog |
| 01/14/1999 | WO1999001452A1 Novel cycloalkyl substituted imidazoles |
| 01/14/1999 | WO1999001136A1 Novel substituted imidazole compounds |
| 01/14/1999 | WO1999001131A1 Novel substituted imidazole compounds |
| 01/14/1999 | WO1999001130A1 Novel substituted imidazole compounds |
| 01/14/1999 | DE19729879A1 Lagerstabile ophthalmische Zusammensetzungen, umfassend Diclofenac und Ofloxacin A storage stable ophthalmic compositions comprising diclofenac and ofloxacin |
| 01/14/1999 | CA2295762A1 Novel cycloalkyl substituted imidazoles |
| 01/14/1999 | CA2295228A1 Novel substituted imidazole compounds |
| 01/14/1999 | CA2294524A1 Novel substituted imidazole compounds |
| 01/14/1999 | CA2294522A1 Novel substituted imidazole compounds |
| 01/13/1999 | EP0890647A2 PcrA, novel polypeptide of the DNA helicases family |
| 01/13/1999 | EP0889894A1 Phosphoramidates and phosphinic amides, their use to modulate the activity of endothelin |
| 01/13/1999 | EP0889877A1 META-SUBSTITUTED PHENYLENE DERIVATIVES AND THEIR USE AS ALPHAvBETA3 INTEGRIN ANTAGONISTS OR INHIBITORS |
| 01/13/1999 | EP0889730A1 Pharmaceutical compositions of botulinum toxin or botulinum neurotoxin and methods of preparation |
| 01/13/1999 | EP0889728A2 Method of treating ciliary dyskinesia with uridine triphosphates and related compounds |
| 01/13/1999 | EP0731787B1 Crystalline, polymorphic form of (s,s,s)-n-(1-[2-carboxy-3-(n2-mesyllysylamino)propyl]-1-cyclopentylcarbonyl)tyrosine |
| 01/13/1999 | EP0671910A4 Glaucoma treatment. |
| 01/13/1999 | EP0555327B1 Alkylidene analogs of 1'-aminospiro-[isoquinoline- 4(1h),3'-pyrrolidine]-1,2',3,5'(2h)-tetrones useful as aldose reductase inhibitors in vivo |
| 01/13/1999 | CN1204528A Medcinal composition for treatment of myopia, amblyopia and preparation method thereof |
| 01/12/1999 | US5859257 Isoxazole compounds as cyclooxygenase inhibitors |
| 01/12/1999 | US5859253 Metalloproteinase inhibitors |
| 01/12/1999 | US5859061 Matrix metalloproteinase inhibitors; treating diseases involving connective tissue degradation |
| 01/12/1999 | US5859015 N-heterocyclic piperazinyl and H-heterocyclic piperazinonyl inhibitors of farnesyl-protein transferase |
| 01/12/1999 | US5859012 Inhibitors of farnesyl-protein transferase |
| 01/12/1999 | US5859006 Tetracyclic derivatives; process of preparation and use |
| 01/12/1999 | US5858718 Pcr a |
| 01/12/1999 | US5858376 Introducing into cell isolated protein derived from herpes simplex virus |
| 01/12/1999 | CA2104917C Use of certain anionic surfactants to enhance antimicrobial effectiveness of ophthalmic compositions |
| 01/08/1999 | CA2236473A1 Novel pcra |
| 01/07/1999 | WO1999000500A1 Calcium-binding phosphoprotein |
| 01/07/1999 | WO1999000420A1 Kringle domains 1-5 of plasminogen, capable of modulating angiogenesis in vivo |
| 01/07/1999 | WO1999000387A1 Novel n-benzenesulphonyl-l-proline compounds, preparation method and use in therapy |
| 01/07/1999 | WO1999000353A1 Novel thyroid receptor ligands and method |
| 01/07/1999 | WO1999000133A1 Method for optimizing retinal and optic nerve health |
| 01/07/1999 | WO1999000129A1 Calcium blockers to treat proliferative vitreoretinopathy |
| 01/07/1999 | EP0889132A2 Streptococcus pneumoniae gidA2 polynucleotides and polypeptides |
| 01/07/1999 | EP0889130A2 GidB polypeptides from Streptococcus pneumoniae |
| 01/07/1999 | EP0889129A2 GidA1 polypeptides from Staphylococcus aureus |
| 01/07/1999 | EP0889128A2 midA1 polypeptides from Streptococcus pneumoniae |
| 01/07/1999 | EP0889123A2 MurC gene of Staphylococcus aureus coding for UDP-N-acetylmuramate:L-alanine Ligase |
| 01/07/1999 | EP0888355A1 Heterocyclic compounds and their preparation and use |
| 01/07/1999 | EP0888344A1 Spirocycle integrin inhibitors |
| 01/07/1999 | EP0888336A1 Novel substituted n-methyl-n-(4-(4-(1h-benzimidazol-2-yl-amino)p iperidin-1-yl)-2-(aryl)butyl)benzamides useful for the treatment of allergic diseases |
| 01/07/1999 | EP0888327A1 Benzopyran derivatives having leukotriene-antagonistic action |
| 01/07/1999 | EP0888309A1 Imidazole derivatives having affinity for alpha2 receptors activity |
| 01/07/1999 | EP0888298A2 Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents |
| 01/07/1999 | CA2295925A1 Kringle domains 1-5 of plasminogen, capable of modulating angiogenesis in vivo |
| 01/07/1999 | CA2295208A1 Calcium-binding phosphoprotein |
| 01/07/1999 | CA2295098A1 Calcium blockers to treat proliferative vitreoretinopathy |
| 01/07/1999 | CA2294343A1 Method for optimizing retinal and optic nerve health |
| 01/07/1999 | CA2293565A1 Novel n-benzenesulphonyl-l-proline compounds, preparation method and use in therapy |
| 01/06/1999 | CN1204344A Transferrin receptor protein of Moraxella |
| 01/06/1999 | CN1204320A Alpha-substituted arylsulphonamido hydroxamic acids as TNF-alpha and matrix metalloproteinase inhibitors |
| 01/05/1999 | US5856354 Tachykinin antagonists |
| 01/05/1999 | US5856329 Method of using (2-imidazolin-2-ylamino) quinoxalines in treating ocular neural injury |
| 01/05/1999 | US5855883 Method of disinsertion of vitreous body from neural retina of the eye with Proteus vulgaris chondroitinases I and II |
| 01/05/1999 | CA2132826C Use of borate-polyol complexes in ophthalmic compositions |
| 01/05/1999 | CA2043366C Dry eye treatment process and solution |
| 01/03/1999 | CA2236462A1 Murc |
| 01/01/1999 | CA2236459A1 Novel compounds |
| 01/01/1999 | CA2236452A1 Gida1 |
| 01/01/1999 | CA2236441A1 Gida2 |
| 01/01/1999 | CA2236425A1 Gida1 |